Is One PRP Injection Enough?
Many patients are treated with a single PRP procedure. This article explains how the number of treatments is determined and what the evidence shows about single versus repeat injections for knee osteoarthritis and tendon disorders.
Is One PRP Injection Enough?
One of the most common questions patients ask before a PRP procedure is whether a single injection will be sufficient, or whether multiple treatments will be needed. The honest answer is that it depends — on the diagnosis, the treatment site, the patient's response, and what the clinical evidence supports for that specific condition.
How Treatment Frequency Is Determined
The decision to repeat a PRP procedure is not made in advance. It is based on the patient's clinical response after the initial treatment. Factors that influence the decision include:
- Diagnosis and disease severity. Mild-to-moderate knee osteoarthritis has a comparatively stronger evidence base for PRP than advanced arthritis. Patients with more advanced disease are less likely to respond to any injection-based treatment, including PRP.
- Treatment site. Tendon conditions and joint conditions may respond differently. Some tendon protocols in the literature used a single injection; others used two or three.
- Response assessment. If a patient has meaningful improvement after one injection, a second is generally not indicated. If there is partial improvement, the clinical picture guides the decision.
- Time since injection. PRP effects, when they occur, typically develop over weeks to months. Reassessment before adequate time has passed does not accurately reflect the treatment's effect.
Additional treatment is not automatically required, and more injections do not reliably produce better outcomes than a single well-placed injection.
What the Evidence Shows for Knee Osteoarthritis
Most randomized controlled trials for PRP in knee osteoarthritis have used one to three injections, with one or three being the most common protocols.
A 2021 meta-analysis by Belk et al. (American Journal of Sports Medicine, 2021; DOI: 10.1177/03635465211007918) found that both single and multiple injection protocols produced improvements in pain and function compared to placebo and hyaluronic acid, but did not find a consistent advantage for multiple injections over a single injection.
A 2022 randomized controlled trial by Bennell et al. (JAMA, 2021; DOI: 10.1001/jama.2021.19415) compared a single PRP injection to saline placebo in 288 patients with symptomatic knee osteoarthritis and found no significant difference in pain or function at 12 months. This is an important negative trial that should be considered alongside positive studies.
The evidence does not support a universal protocol of multiple injections for knee osteoarthritis. Patient selection, disease severity, and preparation type appear to be more important variables than injection number.
What the Evidence Shows for Tendon Conditions
Tendon protocols in the literature vary widely. For lateral epicondylitis (tennis elbow), most randomized trials used a single injection. A 2010 randomized controlled trial by Gosens et al. (American Journal of Sports Medicine, 2011; DOI: 10.1177/0363546510397173) used a single injection and found PRP superior to corticosteroid at one year.
For patellar tendinopathy, protocols have ranged from one to three injections. A 2021 systematic review by Scott et al. (British Journal of Sports Medicine, 2019; DOI: 10.1136/bjsports-2018-099740) found that single-injection protocols produced outcomes comparable to multi-injection protocols, though the evidence base is limited.
What This Means for Patients
Most patients at this practice are treated with a single PRP procedure. If additional treatment is considered, it is based on the clinical response and the evidence for the specific diagnosis — not a predetermined protocol. Patients should not expect that more injections automatically produce better results, and should be cautious of any provider who recommends a fixed multi-injection series without a clinical rationale.
References
- Belk JW, et al. Leukocyte-Poor Platelet-Rich Plasma Is Superior to Leukocyte-Rich Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis. Am J Sports Med. 2021;49(9):2598–2607. DOI: 10.1177/03635465211007918
- Bennell KL, et al. Effect of Intraarticular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis. JAMA. 2021;326(20):2021–2030. DOI: 10.1001/jama.2021.19415
- Gosens T, et al. Ongoing Positive Effect of Platelet-Rich Plasma Versus Corticosteroid Injection in Lateral Epicondylitis. Am J Sports Med. 2011;39(6):1200–1208. DOI: 10.1177/0363546510397173
Reviewed by Joseph Blythe, DO — July 2026 Last medical review: July 31, 2026
Explore Topics
Written & reviewed by
Joseph Blythe, DO — Orthopedic Spine Surgeon
DO | Board-Certified Orthopedic Surgeon | Fellowship-Trained Spine Specialist
Dr. Blythe is a board-certified, fellowship-trained orthopedic and spine surgeon practicing in Oklahoma City. He completed his fellowship at the Spine Institute of Arizona and holds board certification through the American Osteopathic Board of Orthopedic Surgery (AOBO). All articles in the Patient Education Center are authored and medically reviewed by Dr. Blythe.
